Loading...
Please wait, while we are loading the content...
Similar Documents
Uncommon BCR-ABL kinase domain mutations in kinase inhibitor–resistant chronic myelogenous leukemia and Ph+ acute lymphoblastic leukemia show high rates of regression, suggesting weak selective effects
| Content Provider | Scilit |
|---|---|
| Author | Jones, Dan Chen, S. S. Jabbour, Elias Rios, Mary Beth Kantarjian, Hagop Cortes, Jorge |
| Copyright Year | 2010 |
| Description | To the editor: In chronic myelogenous leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia (ALL), extensive data are available on the development of the 15 to 20 most common BCR-ABL1 kinase domain (KD) mutations arising after imatinib treatment and their |
| Related Links | http://www.bloodjournal.org/content/115/26/5428.full.pdf |
| Ending Page | 5429 |
| Page Count | 2 |
| Starting Page | 5428 |
| DOI | 10.1182/blood-2009-11-252155 |
| Journal | Blood |
| Issue Number | 26 |
| Volume Number | 115 |
| Language | English |
| Publisher | American Society of Hematology |
| Publisher Date | 2010-07-01 |
| Access Restriction | Open |
| Subject Keyword | Hematology Chronic Myelogenous Leukemia Acute Lymphoblastic Leukemia Resistant Abl Kinase Uncommon Bcr Bcr Abl Kinase Domain Domain Mutations Journal: Blood (Vol- 2015, Issue- 26) |
| Content Type | Text |
| Resource Type | Article |